W. Marston Linehan

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

4in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Why this DataRank?

An author's DataRank is the sum of the DataRanks of all 4 indexed papers attributed to them. A prolific author with many moderate-impact papers can outrank one with a single high-impact paper.

Author scores recompute whenever paper DataRanks are refreshed, so this number lags the underlying paper scores by at most one batch run.

Read the full methodology →

The highest-impact dataset this researcher has shared, ranked by DataRank — the single contribution doing the most to lift their data-sharing standing.

Data from Molecular Characterization and Therapeutic Targeting of Colorectal Cancers Harboring Receptor Tyrosine Kinase Fusions

(2023)10.1158/1078-0432.c.6530721.v1

Top 100%

0DataRank

Top 100%0 citations

Yvonne Y. Li, Liam F. Spurr, Atul B. Shinagare, Ritika Abhyankar, Emma C. Reilly +25 more

Papers

Driven by 20 papers — median percentile 0. Top paper: “Diminished Efficacy of Programmed Death-(Ligand)1 Inhibition in STK11- and KEAP1-Mutant Lung Adenocarcinoma Is Affected by KRAS Mutation Status”.

Diminished Efficacy of Programmed Death-(Ligand)1 Inhibition in STK11- and KEAP1-Mutant Lung Adenocarcinoma Is Affected by KRAS Mutation Status

Journal of Thoracic Oncology(2021)10.1016/j.jtho.2021.10.013

N/A

8.9DataRank · unranked

377 citations

Kathryn C. Arbour, W. Marston Linehan, Amir Vajdi, Natalie I. Vokes, Lingzhi Hong +28 more

Belzutifan for Renal Cell Carcinoma in von Hippel–Lindau Disease

New England Journal of Medicine(2021)10.1056/nejmoa2103425

N/A

4.7DataRank · unranked

664 citations

Frede Donskov, Othon Iliopoulos, W. Kimryn Rathmell, Vivek K. Narayan, Benjamin L. Maughan +10 more

ALK-positive lung cancer: a moving target

Nature Cancer(2023)10.1038/s43018-023-00515-0

N/A

4.3DataRank · unranked

176 citations

W. Marston Linehan, Alice T. Shaw, Jaime L. Schneider

Efficacy and Safety of Larotrectinib in Patients With Tropomyosin Receptor Kinase Fusion–Positive Lung Cancers

JCO Precision Oncology(2022)10.1200/po.21.00418

N/A

1.9DataRank · unranked

87 citations

Daniel S.W. Tan, Ulrik Lassen, Serge Leyvraz, Yongmei Liu, Jyoti D. Patel +10 more

Therapy-induced APOBEC3A drives evolution of persistent cancer cells

Nature(2023)10.1038/s41586-023-06303-1

N/A

0.753DataRank · unranked

150 citations

Ramin Sakhtemani, Ammal Abbasi, Naveed Nikpour, Marcello Stanzione, Sunwoo Oh +36 more

NVL-655 Is a Selective and Brain-Penetrant Inhibitor of Diverse ALK-Mutant Oncoproteins, Including Lorlatinib-Resistant Compound Mutations

Cancer Discovery(2024)10.1158/2159-8290.cd-24-0231

N/A

0.587DataRank · unranked

49 citations

Joshua C. Horan, Anupong Tangpeerachaikul, Aurélie Swalduz, Augusto Valdivia, Melissa L. Johnson +23 more

Molecular Characterization and Therapeutic Targeting of Colorectal Cancers Harboring Receptor Tyrosine Kinase Fusions

Clinical Cancer Research(2021)10.1158/1078-0432.ccr-20-4073

N/A

0.538DataRank · unranked

35 citations

Yvonne Y. Li, Liam F. Spurr, Atul B. Shinagare, Ritika Abhyankar, Emma Reilly +25 more

Response to Immune Checkpoint Inhibition as Monotherapy or in Combination With Chemotherapy in Metastatic ROS1-Rearranged Lung Cancers

JTO Clinical and Research Reports(2021)10.1016/j.jtocrr.2021.100187

N/A

0.529DataRank · unranked

33 citations

Jaime L. Schneider, Tejas Patil, Viola W. Zhu, Debra A. Goldman, Soo-Ryum Yang +13 more

Genome-Wide Analysis Identifies Nuclear Factor 1C as a Novel Transcription Factor and Potential Therapeutic Target in SCLC

Journal of Thoracic Oncology(2024)10.1016/j.jtho.2024.03.023

N/A

0.398DataRank · unranked

8 citations

Haitao Wang, Lyuba Varticovski, Songjoon Baek, Ruihong Wang, Xinwei Wu +13 more

LKB1 regulates JNK-dependent stress signaling and apoptotic dependency of KRAS-mutant lung cancers

Nature Communications(2025)10.1038/s41467-025-58753-y

N/A

0.345DataRank · unranked

9 citations

Mohammed U. Syed, Anahita Nimbalkar, Yi Shen, Melissa D. Vieira, Cameron Fraser +24 more

The Genetic Basis of Kidney Cancer and Implications for Targeted Therapies

Renal Cell Carcinoma(2012)10.1007/978-1-4614-2400-0_1

N/A

0.241DataRank · unranked

4 citations

Ramaprasad Srinivasan, W. Marston Linehan, Laura S. Schmidt

Managing Renal Cell Carcinoma Associated Paraneoplastic Syndrome with Nephron-sparing Surgery in a Patient with von Hippel-Lindau

Urology Case Reports(2017)10.1016/j.eucr.2017.02.015

N/A

0.104DataRank · unranked

1 citations

Julie Y. An, Sally Tanakchi, Zachary Stanik, Aidan McGowan, Mahir Maruf +9 more

Efficacy and Tolerability of ALK/MET Combinations in Patients With ALK-Rearranged Lung Cancer With Acquired MET Amplification: A Retrospective Analysis

JTO Clinical and Research Reports(2023)10.1016/j.jtocrr.2023.100534

N/A

0DataRank · unranked

13 citations

Lesli A. Kiedrowski, Rebecca S. Heist, W. Marston Linehan, Catherine B. Meador, Elizabeth Krueger +7 more

Clinical Acquired Resistance to KRASG12C Inhibition through a Novel KRAS Switch-II Pocket Mutation and Polyclonal Alterations Converging on RAS–MAPK Reactivation

Cancer Discovery(2021)10.1158/2159-8290.cd-21-0365

N/A

0DataRank · unranked

520 citations

W. Marston Linehan, Chendi Li, Meagan B. Ryan, Junbing Zhang, Lesli A. Kiedrowski +15 more

LKB1 loss rewires JNK-induced apoptotic protein dynamics through NUAKs and sensitizes KRAS-mutant NSCLC to combined KRASG12C + MCL-1 blockade

Research Square(2022)10.21203/rs.3.rs-2334763/v1

N/A

0DataRank · unranked

0 citations

Chendi Li, Mohammed U. Syed, Yi Shen, Cameron Fraser, Jian Ouyang +16 more

Tobacco smoking induces metabolic reprogramming of renal cell carcinoma

Journal of Clinical Investigation(2020)10.1172/jci140522

N/A

0DataRank · unranked

54 citations

Dina Secic, Jacek Biesiada, Collin Wetzel, Behrouz Shamsaei, Johnson Chu +19 more

Lorlatinib and capmatinib in a ROS1-rearranged NSCLC with MET-driven resistance: tumor response and evolution

npj Precision Oncology(2023)10.1038/s41698-023-00464-y

N/A

0DataRank · unranked

8 citations

Khvaramze Shaverdashvili, Mari Mino–Kenudson, Subba R. Digumarthy, Andrew Do, Audrey Liu +5 more

Data from Molecular Characterization and Therapeutic Targeting of Colorectal Cancers Harboring Receptor Tyrosine Kinase Fusions

(2023)10.1158/1078-0432.c.6530721.v1

Top 100%

0DataRank

Top 100%0 citations

Yvonne Y. Li, Liam F. Spurr, Atul B. Shinagare, Ritika Abhyankar, Emma C. Reilly +25 more

Efficacy and Safety of Dose-Escalated Alectinib in Patients With Metastatic ALK-Positive NSCLC and Central Nervous System Relapse on Standard-Dose Alectinib

JTO Clinical and Research Reports(2024)10.1016/j.jtocrr.2024.100645

N/A

0DataRank · unranked

4 citations

Jiyoon Kang, Beow Y. Yeap, Jennifer Peterson, Andrew Do, Justin F. Gainor +3 more

Metabolic evaluation of sporadic papillary kidney cancer.

Journal of Clinical Oncology(2012)10.1200/jco.2012.30.5_suppl.377

N/A

0DataRank · unranked

0 citations

Christopher Ricketts, Carole Sourbier, Shinji Tsutsumi, Xiu-ying Zhang, Arie S. Belldegrun +4 more

W. Marston Linehan

Indexed papers

Top data-sharing exemplar

Papers